about
The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand bindingQuantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environmentC5L2: a controversial receptor of complement anaphylatoxin, C5aComplement component 5a (C5a)Therapeutic activity of C5a receptor antagonists in a rat model of neurodegenerationComplement inhibitors selectively attenuate injury following administration of cobra venom factor to ratsComplement factors C3a and C5a have distinct hemodynamic effects in the rat.Developmental activities of the complement pathway in migrating neurons.Neural tube defects, folate, and immune modulation.Complement C5a-C5aR1 signalling drives skeletal muscle macrophage recruitment in the hSOD1G93A mouse model of amyotrophic lateral sclerosis.Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's diseaseSerping1/C1 Inhibitor Affects Cortical Development in a Cell Autonomous and Non-cell Autonomous Manner.Placental lipases in pregnancies complicated by gestational diabetes mellitus (GDM).Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal deathCrosstalk between TGF-β1 and complement activation augments epithelial injury in pulmonary fibrosis.Is the complement activation product C3a a proinflammatory molecule? Re-evaluating the evidence and the myth.The Complement Receptor C5aR Controls Acute Inflammation and Astrogliosis following Spinal Cord Injury.Pathophysiology, treatment, and animal and cellular models of human ischemic stroke.Derivation of ligands for the complement C3a receptor from the C-terminus of C5aComparative efficacy of a secretory phospholipase A2 inhibitor with conventional anti-inflammatory agents in a rat model of antigen-induced arthritis.Insights into the mechanism of C5aR inhibition by PMX53 via implicit solvent molecular dynamics simulations and dockingAbsence of toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis.Antiallodynic effects of alpha lipoic acid in an optimized RR-EAE mouse model of MS-neuropathic pain are accompanied by attenuation of upregulated BDNF-TrkB-ERK signaling in the dorsal horn of the spinal cord.De novo peptide design with C3a receptor agonist and antagonist activities: theoretical predictions and experimental validation.Discovery of functionally selective C5aR2 ligands: novel modulators of C5a signalling.Placental lipase expression in pregnancies complicated by preeclampsia: a case-control studyThe Receptor for Advanced Glycation Endproducts Does Not Contribute to Pathology in a Mouse Mesenteric Ischemia/Reperfusion-Induced Injury Model.Complement mediators in ischemia-reperfusion injury.Autoantibodies against homocysteinylated protein in a mouse model of folate deficiency-induced neural tube defects.C5a receptor signaling prevents folate deficiency-induced neural tube defects in miceThe Complement System Component C5a Produces Thermal Hyperalgesia via Macrophage-to-Nociceptor Signaling That Requires NGF and TRPV1Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization.Targeting ischemic brain injury with intravenous immunoglobulin.T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4⁺ T cells.Toll-like receptors in ischemia-reperfusion injury.Prokineticin-2 upregulation during neuronal injury mediates a compensatory protective response against dopaminergic neuronal degeneration.Dysregulation of the complement cascade in the hSOD1G93A transgenic mouse model of amyotrophic lateral sclerosis.The C5a anaphylatoxin receptor CD88 is expressed in presynaptic terminals of hippocampal mossy fibres.The role of the complement system and the activation fragment C5a in the central nervous system.
P50
Q24610523-0E7ABC43-2368-4629-983B-7A8FF8A13BD9Q24633514-FC0D027C-D717-4565-B2D3-43C7FAD00DC4Q27012650-EA6FF095-06E0-47E2-9FBD-C1466A45D501Q28246030-86A06C93-C2F9-41FB-ABDB-16D6A254D61CQ28249885-5FE7CA8D-91C8-4392-912C-F0388BC9869DQ28565457-44DF2A00-02B1-4F48-8AD4-6A21DDABB0FDQ29347019-FE6450FC-263C-44A2-8FF5-1E18593980D9Q33640039-DE7E9BE0-7154-494F-A197-6A4C68AA136EQ33739571-14303208-254A-4100-8D5F-B1FF80A04B0FQ33756216-EF2A69A9-0F5F-487C-AD79-F5DF404896A9Q33793485-38BBFF73-2637-4509-8A2C-68516BEB0752Q33804415-45E4A679-1D91-461A-A774-7F98166488F3Q34035480-3848974E-9AEA-453A-8394-5E6CE80F7036Q34075006-9AFE2205-A47D-4B71-8134-87F6E83AEACFQ34365488-09B3E202-8BB9-4C23-8894-4F14C91E2E4CQ34470575-50D5CF95-8D82-4B7E-A585-D55109766941Q34473321-0552721B-4898-47BE-9227-78273B52C77BQ34569654-1FDC97E4-E418-498F-A0E2-6B59B4E359BCQ34680953-0E0B0E3E-3DA6-410E-931C-04C987A4F3AEQ35092909-96B7C1E4-12D0-42ED-9EF0-0A0D73309D6BQ35234686-0811E1C3-BDDE-4EA6-9FF2-E76ABA0A8DFBQ35605786-38C352CA-CE7F-4F17-A535-2D1972E6000FQ35822338-8E6EED04-68C4-49DA-91D4-5812F1A4F4ACQ35951590-A4CB3BD5-76DA-4E08-B81E-9FF432B6C2EEQ35997737-EA47C249-F888-4350-B947-01AA8C993D7EQ36023029-0F3E587D-9CD4-4EEA-A4A0-98B48887A502Q36349738-9B3EAEF2-D137-4147-A487-250D7CEA9ACEQ36548838-B6C430BA-4D86-44D0-B67C-D52EE68B5A42Q36712032-F0FA8D95-F5CF-4987-B97E-A69D79998193Q36718193-C94F02D9-98C2-4564-B532-55F95842E554Q36863976-62816282-6357-411D-ACBF-3EDD167F2F1BQ36913772-E1502451-5C0A-49AF-889A-172DC718CC8AQ36915584-2980EE10-0C0D-4DA4-9439-CC8616A8F3CEQ37030865-C71BFEB8-F650-4958-BEF2-9E34F082E9CDQ37241002-5F59948D-92D6-4B69-A394-8A696C41725AQ37325430-2991A985-5293-4101-BAEE-DEEA714028ABQ37329938-56AE4B7A-C300-42E5-9751-48BB9CBC358FQ37363769-A7EE8896-FACB-4F18-9E59-70B0C960A6CEQ37428162-3189527E-C6AB-4AA0-9AE7-BAB9CE097975Q37599686-6AF23DE9-5EA6-4C9E-BBA0-066E86CCD48E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Trent M. Woodruff
@ast
Trent M. Woodruff
@en
Trent M. Woodruff
@es
Trent M. Woodruff
@nl
Trent M. Woodruff
@sl
type
label
Trent M. Woodruff
@ast
Trent M. Woodruff
@en
Trent M. Woodruff
@es
Trent M. Woodruff
@nl
Trent M. Woodruff
@sl
altLabel
Trent M. Woodruff
@en
prefLabel
Trent M. Woodruff
@ast
Trent M. Woodruff
@en
Trent M. Woodruff
@es
Trent M. Woodruff
@nl
Trent M. Woodruff
@sl
P1053
B-4861-2009
P106
P1153
7005693216
P21
P2798
P31
P3829
P496
0000-0003-1382-911X